Skip to main content
. 2016 Dec 5;129(5):572–581. doi: 10.1182/blood-2016-07-726588

Table 4.

UVA and MVA for OS (including Ph-like and B-other group) (N = 109)

Parameter Survival
n Median, mo UVA MVA
P P HR 95% CI
Age, y
 ≥60 19 9.2 .001 <.001 3.299 1.745-6.235
 <60 90 50.2
Sex
 Female 53 63.8 .21
 Male 56 34.6
Ethnicity (Hispanic)
 Yes 54 32.5 .22
 No 55 63.8
WBC, ×109/L
 ≥30.0 29 18.8 .007 .017 1.910 1.117-3.266
 <30 80 53.7
Hemoglobin, g/dL
 <10 75 37.3 .53
 ≥10 34 38.9
Platelet, ×109/L
 <100 91 29.5 <.001 .005 7.437 1.792-30.855
 ≥100 18 NR
CNS involvement at Dx
 Yes 14 28.8 .81
 No 95 38.9
Ph-like ALL
 Yes 56 28.9 .006 .030 1.818 1.056-3.128
 No 53 NR
Treatment received
 Hyper-CVAD 78 33.1 .24
 Augmented BFM 31 48.8

CI, confidence interval; NR, not reached.